SHORT BOWEL SYNDROME (SBS)
Clinical trials for SHORT BOWEL SYNDROME (SBS) explained in plain language.
Never miss a new study
Get alerted when new SHORT BOWEL SYNDROME (SBS) trials appear
Sign up with your email to follow new studies for SHORT BOWEL SYNDROME (SBS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common diabetes drug help heal the gut in short bowel syndrome?
Disease control Recruiting nowThis study tests whether semaglutide, a drug used for diabetes, can improve intestinal barrier function in adults with short bowel syndrome who need intravenous nutrition. Twenty participants will receive either semaglutide or a placebo for 28 days. Researchers will measure blood…
Matched conditions: SHORT BOWEL SYNDROME (SBS)
Phase: NA • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New hope for kids with short bowel: can a drug cut the need for IV feeding?
Disease control Recruiting nowThis study looks at whether a drug called teduglutide can help children aged 1 to 17 with short bowel syndrome reduce the amount of nutrition they get through a vein. The study will review past medical records and collect new data from about 12 children in China. The goal is to s…
Matched conditions: SHORT BOWEL SYNDROME (SBS)
Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Mini-Organs shed light on why some kids respond better to gut drug
Knowledge-focused Recruiting nowThis study looks at why children with short bowel syndrome (a rare condition where part of the intestine is missing) respond differently to the drug teduglutide. Researchers will grow tiny, lab-made versions of the children's intestines (called organoids) from tissue samples take…
Matched conditions: SHORT BOWEL SYNDROME (SBS)
Phase: NA • Sponsor: Meyer Children's Hospital IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Do you really know your meds? new survey tests GATTEX safety smarts
Knowledge-focused Recruiting nowThis study uses a survey to see how well patients and doctors understand the risks and required checkups for the drug GATTEX, used to treat Short Bowel Syndrome. About 600 people—adults who have taken GATTEX in the last 60 days and their healthcare providers—will answer true/fals…
Matched conditions: SHORT BOWEL SYNDROME (SBS)
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC